GEIST:UPC Searchengine

ORD_60219/2024

Alexion Pharmaceuticals, Inc. v. Samsung Bioepis NL B.V.

Datum
2024-12-20
Kammer
Luxembourg (LU)
Verfahrensart
Appeal RoP220.1
Sprache
EN

Metadaten

Fall-IDORD_60219-2024-f6579fcd3557
Aktenzeichen
RegisterzeichenORD_60219/2024
EntscheidungsreferenzORD_60219/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 16

1 FINAL ORDER of the Court of Appeal of the Unified Patent Court concerning an application for provisional measures issued on 20 December 2024 HEADNOTE 1. A linguistic error, a spelling mistake or any other inaccuracy in a patent claim can only be corrected by way of interpretation of the patent claim if the existence of an error and the precise way to correct it are sufficiently certain to the average skilled person on the basis of the patent claim, taking into account the description and the drawings and using common general knowledge. 2. The patent claim must be interpreted from the perspective of the person skilled in the art. The applicant’s assertions during the grant proceedings, and in particular the TBA’s endorsement thereof, can be seen as an indication of the view of the person  ...